Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 578-585

  Redman, Rebecca L ^a   Nader, Sonia ^a   Zerboni, Leigh ^a   Liu, Catherine ^a   Wong, Ruby M ^a   Brown, Byron W ^a   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; CHICKENPOX VACCINE; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10;

ACTIVE IMMUNIZATION; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; HERPES ZOSTER; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VARICELLA ZOSTER VIRUS; VIRUS PATHOGENESIS;

EID: 0030750173     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514077     Document Type: Article

References (15)

1. Locksley RM, Flournoy N, Sullivan KM, Meyers JD. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 1985;152: 1172-81.
2. Meyers JD, Flournoy N, Thomas ED. Cell-mediated immunity to varicellazoster virus after allogeneic marrow transplant. J Infect Dis 1980;141: 479-87.
3. Wilson A, Sharp M, Koropchak CM, Ting SF, Arvin AM. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster virus antigens after bone marrow transplantation. J Infect Dis 1992;165:119-26.
4. Lopez C, Simmons R. Cytomegalovirus infections in renal and bone marrow transplantation. In: Touraine JP, ed. Transplantation and clinical immunology. Vol IX. Amsterdam: Excerpta Medica, 1989:17.
5. Wacker P, Hartmann O, Benhamou E, Salloum E, Lemerle J. Varicellazoster virus infections after autologous bone marrow transplantation in children. Bone Marrow Transplant 1989;4:191-4.
6. Blume KG, Beutler E, Bross KJ, et al. Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. N Engl J Med 1980; 302:1041-6.
7. Atkinson K, Meyers JD, Storb R, Prentice RL, Thomas ED. Varicellazoster virus infection after marrow transplantation for aplastic anemia or leukemia. Transplantation 1980;29:47-50.
8. Atkinson K, Farewell V, Storb R, et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 1982;60:714-20.
9. Ljungman P, Lonnqvist B, Gahrton G, Ringden O, Sundqvist VA, Wahren B. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J Infect Dis 1986;153:840-7.
10. Schuchter LM, Wingard JR, Piantadosi S, Burns WH, Santos GW, Saral R. Herpes zoster infection after autologous bone marrow transplantation. Blood 1989;74:1424-7.
11. Christiansen N, Haake R, Hurd D. Early herpes zoster in adult patients with Hodgkin's disease undergoing bone marrow transplantation. Bone Marrow Transplant 1991;7:435-7.
12. Shepp DH, Dandliker PS, Meyers JD. Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine. N Engl J Med 1986;314:208-12.
13. Meyers JD, Wade JC, Shepp DH, Newton B. Acyclovir treatment of varicella-zoster virus infection in the compromised host. Transplantation 1984:37:571-4.
14. Krause PR, Klinman DM. Efficacy, immunogenicity, safety and use of live attenuated chickenpox vaccine. J Pediatr 1995;27:518-25.
15. Recommendations for the use of live attenuated varicella vaccine. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 1995;95:791-6.